Development and validation of a new histological score for pediatric non-alcoholic fatty liver disease

Journal of Hepatology

Volumn 57, Issue 6, 2012, Pages 1312-1318

  Alkhouri, Naim ^a   De Vito, Rita ^b   Alisi, Anna ^b   Yerian, Lisa ^a   Lopez, Rocio ^a   Feldstein, Ariel E ^c   Nobili, Valerio ^b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Children; Histological score; Non alcoholic fatty liver disease; Non alcoholic steatohepatitis; Portal inflammation

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; GAMMA GLUTAMYLTRANSFERASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

AGE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; AREA UNDER THE CURVE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BODY MASS; CHILD; CHOLESTEROL BLOOD LEVEL; DIABETES MELLITUS; DISEASE SEVERITY; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HISTOPATHOLOGY; HOMEOSTASIS; HUMAN; HUMAN TISSUE; HYPERTENSION; INFLAMMATION; INTERNATIONAL NORMALIZED RATIO; LIVER BIOPSY; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; PEDIATRIC NON ALCOHOLIC FATTY LIVER DISEASE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SCHOOL CHILD; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; STEATOSIS; TRIACYLGLYCEROL BLOOD LEVEL; VALIDATION STUDY; WAIST CIRCUMFERENCE;

ADOLESCENT; CHILD; FATTY LIVER; FEMALE; HUMANS; LIVER; LIVER CIRRHOSIS; MALE;

EID: 84869238673     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2012.07.027     Document Type: Article

References (31)

1. P. Angulo Non-alcoholic fatty liver disease N Eng J Med 346 2002 1221 1231
2. E.M. Brunt, and D.G. Tiniakos Pathological features of NASH Front Biosci 10 2005 1475 1484
3. A.E. Feldstein, P. Charatcharoenwitthaya, S. Treeprasertsuk, J.T. Benson, F.B. Enders, and P. Angulo The natural history of non-alcoholic fatty liver disease in children: a follow-up study for up to 20 years Gut 58 2009 1538 1544
4. A. Wieckowska, and A.E. Feldstein Diagnosis of non-alcoholic fatty liver disease: invasive versus noninvasive Semin Liver Dis 28 2008 386 395
5. E.M. Brunt, C.G. Janney, A.M. Di Bisceglie, B.A. Neuschwander-Tetri, and B.R. Bacon Non-alcoholic steatohepatitis: a proposal for grading and staging the histological lesions Am J Gastroenterol 94 1999 2467 2474
6. J. Ludwig, T.R. Viggiano, D.B. McGill, and B.J. Oh Non-alcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease Mayo Clin Proc 55 1980 434 438
7. M.H. Mendler, G. Kanel, and S. Govindarajan Proposal for a histological scoring and grading system for non-alcoholic fatty liver disease Liver Int 25 2005 294 304
8. D.E. Kleiner, E.M. Brunt, M. Van Natta, C. Behling, M.J. Contos, and O.W. Cummings Design and validation of a histological scoring system for non-alcoholic fatty liver disease Hepatology (Baltimore, MD) 41 2005 1313 1321
9. C. Carter-Kent, L.M. Yerian, E.M. Brunt, P. Angulo, R. Kohli, and S.C. Ling Non-alcoholic steatohepatitis in children: a multicenter clinicopathological study Hepatology (Baltimore, MD) 50 2009 1113 1120
10. H. Patton, J.E. Lavine, M.L. Van Natta, J.B. Schwimmer, D. Kleiner, and J. Molleston Clinical correlates of histopathology in pediatric non-alcoholic steatohepatitis Gastroenterology 2008
11. J.B. Schwimmer, C. Behling, R. Newbury, R. Deutsch, C. Nievergelt, and N.J. Schork Histopathology of pediatric non-alcoholic fatty liver disease Hepatology (Baltimore, MD) 42 2005 641 649
12. V. Nobili, M. Marcellini, R. Devito, P. Ciampalini, F. Piemonte, and D. Comparcola NAFLD in children: a prospective clinical-pathological study and effect of lifestyle advice Hepatology (Baltimore, MD) 44 2006 458 465
13. S. Caldwell, Y. Ikura, D. Dias, K. Isomoto, A. Yabu, and C. Moskaluk Hepatocellular ballooning in NASH J Hepatol 53 2010 719 723
14. J.E. Lavine, J.B. Schwimmer, M.L. Van Natta, J.P. Molleston, K.F. Murray, and P. Rosenthal Effect of vitamin E or metformin for treatment of non-alcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial JAMA 305 2011 1659 1668
15. A.J. Sanyal, N. Chalasani, K.V. Kowdley, A. McCullough, A.M. Diehl, and N.M. Bass Pioglitazone, vitamin E, or placebo for non-alcoholic steatohepatitis N Engl J Med 362 2010 1675 1685
16. R.J. Kuczmarski, C.L. Ogden, L.M. Grummer-Strawn, K.M. Flegal, S.S. Guo, and R. Wei CDC growth charts: United States Adv Data 2000 1 27
17. T.J. Cole, M.C. Bellizzi, K.M. Flegal, and W.H. Dietz Establishing a standard definition for child overweight and obesity worldwide: international survey BMJ (Clinical Research Ed) 320 2000 1240 1243
18. C.M. Boney, A. Verma, R. Tucker, and B.R. Vohr Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitus Pediatrics 115 2005 e290 e296
19. J.R. Fernandez, D.T. Redden, A. Pietrobelli, and D.B. Allison Waist circumference percentiles in nationally representative samples of African-American, European-American, and Mexican-American children and adolescents J Pediatr 145 2004 439 444
20. American Academy of Pediatrics National cholesterol education program: report of the expert panel on blood cholesterol levels in children and adolescents Pediatrics 89 1992 525 584
21. Report of the Second Task Force on Blood Pressure Control in Children - 1987. Task Force on Blood Pressure Control in Children. National Heart, Lung, and Blood Institute, Bethesda, Maryland Pediatrics 79 1987 1 25
22. S. Genuth, K.G. Alberti, P. Bennett, J. Buse, R. Defronzo, and R. Kahn Follow-up report on the diagnosis of diabetes mellitus Diabetes Care 26 2003 3160 3167
23. E.M. Brunt, D.E. Kleiner, L.A. Wilson, A. Unalp, C.E. Behling, and J.E. Lavine Portal chronic inflammation in non-alcoholic fatty liver disease (NAFLD): a histologic marker of advanced NAFLD-clinicopathologic correlations from the non-alcoholic steatohepatitis clinical research network Hepatology (Baltimore, MD) 49 2009 809 820
24. L.A. Adams, J.F. Lymp, J. St Sauver, S.O. Sanderson, K.D. Lindor, and A. Feldstein The natural history of non-alcoholic fatty liver disease: a population-based cohort study Gastroenterology 129 2005 113 121
25. M. Ekstedt, L.E. Franzen, U.L. Mathiesen, L. Thorelius, M. Holmqvist, and G. Bodemar Long-term follow-up of patients with NAFLD and elevated liver enzymes Hepatology (Baltimore, MD) 44 2006 865 873
26. C.A. Matteoni, Z.M. Younossi, T. Gramlich, N. Boparai, Y.C. Liu, and A.J. McCullough Non-alcoholic fatty liver disease: a spectrum of clinical and pathological severity Gastroenterology 116 1999 1413 1419
27. A. Wieckowska, N.N. Zein, L.M. Yerian, A.R. Lopez, A.J. McCullough, and A.E. Feldstein In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in non-alcoholic fatty liver disease Hepatology (Baltimore, MD) 44 2006 27 33
28. T.A. Tamimi, M.P. Berk, N. Alkhouri, L.M. Yerian, R. Lopez, and N.N. Zein An apoptosis panel for non-alcoholic steatohepatitis diagnosis Gastroenterology 136 2009 A89
29. A.J. Sanyal, E.M. Brunt, D.E. Kleiner, K.V. Kowdley, N. Chalasani, and J.E. Lavine Endpoints and clinical trial design for non-alcoholic steatohepatitis Hepatology (Baltimore, MD) 54 2011 344 353
30. M.M. Yeh, and E.M. Brunt Pathology of non-alcoholic fatty liver disease Am J Clin Pathol 128 2007 837 847
31. S.H. Caldwell, V.D. Lee, D.E. Kleiner, A.M. Al-Osaimi, C.K. Argo, and P.G. Northup NASH and cryptogenic cirrhosis: a histological analysis Ann Hepatol 8 2009 346 352